Executive Summary
A cluster of 8 delisting notices (Item 3.01) across small-cap firms on January 9, 2026, signals acute corporate distress, with companies like Advantage Solutions, Tempest Therapeutics, and Fat Brands facing failure to meet NYSE/Nasdaq listing standards, likely tied to financial weakness amid a challenging market. Over 20 filings disclose material definitive agreements (Item 1.01), often paired with new financial obligations (Item 2.03) or equity issuances (Item 3.02), suggesting widespread restructuring or emergency financing efforts. Cumulative impact points to systemic pressure on micro/small-caps, elevating bankruptcy risks and warranting portfolio de-risking in vulnerable sectors.
Tracking the trend? Catch up on the prior US Corporate Distress Financial Stress SEC Filings digest from January 07, 2026.
Investment Signals(4)
- ▲
Cluster of 8 delistings eroding liquidity and investor confidence [BEARISH] - Advantage Solutions, Onfolio Holdings, Lakeside Holding, Tempest Therapeutics, LM Funding America, Fat Brands, TruGolf Holdings, Brag House Holdings
- ▲
FormFactor impairments and exit costs indicate asset write-downs and restructuring [BEARISH] - FormFactor Inc.
- ▲
Frequent material agreements with financial obligations may enable short-term survival but signal dilution [BEARISH] - MSP Recovery, ProFrac Holding, Western Union, NKGen Biotech
- ▲
Undisclosed agreements in biotech firms could hide turnaround financing [BULLISH - conditional] - Arrowhead Pharmaceuticals, Aptevo Therapeutics, Monte Rosa Therapeutics
Risk Flags(4)
- ▼
Surge in delistings (24% of filings) flags broad non-compliance with listing rules, risking OTC trading and illiquidity contagion across small-caps
- ▼
Recurrent Item 2.03/2.04 disclosures (e.g., MSP Recovery, ProFrac) highlight accelerating debt obligations, heightening default risks
- ▼
Widespread unregistered equity sales (Item 3.02) in 6+ firms threaten shareholder dilution amid opaque material agreements
- ▼
Lack of quantitative details in 90%+ of filings obscures true distress magnitude, amplifying uncertainty
Opportunities(4)
- ◆
Short delisting candidates pre-transfer to OTC for liquidity-driven downside [ALPHA] - Tempest Therapeutics, Fat Brands, TruGolf Holdings
- ◆
Distressed M&A plays in firms entering material agreements (e.g., potential asset sales) [ALPHA] - ProFrac Holding, NKGen Biotech
- ◆
Long volatility or protective puts on biotech cluster amid financing deals [ALPHA] - Arrowhead, Monte Rosa, BRAINSTORM Cell Therapeutics
- ◆
Opportunistic debt acquisition if Item 2.03 obligations reveal covenant breaches [ALPHA] - Western Union, MSP Recovery
Sector Themes(3)
- ◆
Biotech/pharma microcaps under duress with delistings and equity raises (Tempest, Aptevo, Monte Rosa, NKGen), pointing to funding droughts
- ◆
Broad small-cap restructuring wave via undisclosed agreements and obligations, correlating delistings with dilution tactics
- ◆
Restructuring signals in diversified industrials/energy (ProFrac, FormFactor) amid impairments and exits
Watch List(4)
- 👁
Delisting cluster (Advantage Solutions, Fat Brands et al.) - Track OTC transfers and bankruptcy petitions within 30 days
- 👁
FormFactor Inc. - Monitor follow-on disclosures on impairment scale and disposal costs for sector contagion
- 👁
Biotech agreements (Arrowhead, Monte Rosa, NKGen) - Scrutinize exhibits for financing terms or acquirer identities
- 👁
MSP Recovery/ProFrac financial obligations - Watch for covenant breaches or acceleration events (Item 2.04)
Filing Analyses(33)
09-01-2026
Arrowhead Pharmaceuticals, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-007971, Size: 1 MB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, transaction values, or financial impacts provided in the available information.
09-01-2026
FormFactor Inc filed an 8-K on January 9, 2026 (AccNo: 0001039399-26-000002, Size: 145 KB), disclosing under Item 2.05 Costs Associated with Exit or Disposal Activities and Item 2.06 Material Impairments. No specific dollar values, transaction details, strategic context, financial impacts, or other quantitative data are provided in the filing summary. This appears to be a multi-item mandatory disclosure signaling potential restructuring and asset write-downs.
09-01-2026
La Rosa Holdings Corp. filed a Form 8-K on January 9, 2026 (AccNo: 0001213900-26-002685, Size: 3 MB), reporting multiple material events including Entry into a Material Definitive Agreement (Item 1.01), Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement (Item 2.03), Unregistered Sales of Equity Securities (Item 3.02), Material Modifications to Rights of Security Holders (Item 3.03), and Amendments to Articles of Incorporation or Bylaws (Item 5.03), with Financial Statements and Exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or quantitative impacts disclosed in the provided summary. Sector is not specified.
09-01-2026
Buda Juice LLC filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001094, Size: 1 MB), reporting multiple items including Item 1.01 (Entry into a Material Definitive Agreement), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item material event filing from the US SEC with sector not specified. No specific transaction details, dollar values, named entities beyond the filer, financial metrics, or other quantitative data are disclosed in the provided information.
09-01-2026
Advantage Solutions Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008903, Size: 254 KB), reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No additional details on delisting reasons, financial impacts, transaction values, or sector are disclosed. This indicates a delisting event from the US market.
09-01-2026
Aptevo Therapeutics Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008318, size: 700 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, equity sales, events, or quantitative data provided in the summary. Sector not specified.
09-01-2026
Onfolio Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001654954-26-000212, Size: 165 KB) disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, including transfer of listing. No specific reasons, financial details, transaction values, or quantitative impacts are provided in the available information. Sector is not specified.
09-01-2026
Aclarion, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001683168-26-000168, size 682 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. This is a multi-item mandatory disclosure of a core material event involving an unspecified agreement. No transaction details, financial metrics, or dollar values are disclosed.
09-01-2026
The filer submitted a Form 8-K on January 9, 2026 (AccNo: 0001661306-26-000004, size 190 KB), reporting under Item 1.01 entry into a Material Definitive Agreement and under Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, parties involved, or financial impacts are disclosed in the provided filing summary. Event classified as Material Event from US SEC source.
09-01-2026
OFS Capital Corp filed a Form 8-K on January 9, 2026 (AccNo: 0001487918-26-000006, size 243 KB), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No details on the agreement's nature, parties, terms, value, or financial impacts are provided in the filing summary. Sector is not specified.
09-01-2026
Venu Holding Corp filed a Form 8-K on January 09, 2026 (AccNo: 0001493152-26-001075, Size: 2 MB), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), and financial statements and exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or financial metrics disclosed in the provided summary. Sector not specified.
09-01-2026
MSP Recovery, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008897, size 1 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 2.04 triggering events accelerating or increasing such obligations, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided information. Sector not specified.
09-01-2026
JOINT Corp filed a Form 8-K on January 9, 2026 (AccNo: 0001612630-26-000004, Size: 166 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement. Item 9.01 includes Financial Statements and Exhibits. No details on the agreement, transaction value, parties, or financial impacts are disclosed.
09-01-2026
Lakeside Holding Ltd filed a Form 8-K on January 9, 2026 (AccNo: 0001213900-26-002910, size 193 KB) under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, with transfer of listing. Sector not specified. No additional details on reasons, financial impacts, transaction values, or other metrics disclosed.
09-01-2026
ProFrac Holding Corp. filed a Form 8-K on January 9, 2026 (AccNo: 0001104659-26-002446, Size: 306 KB), reporting under Item 1.01 entry into a material definitive agreement and Item 2.03 creation of a direct financial obligation or obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, parties, or quantitative metrics are provided in the filing summary.
09-01-2026
zSpace, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001104659-26-002478, Size: 219 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the nature of the agreement, transaction value, counterparties, or exhibits are disclosed in the provided summary. Sector is not specified.
09-01-2026
Tempest Therapeutics, Inc. filed a Form 8-K on 2026-01-09 (AccNo: 0001193125-26-008938, Size: 174 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. This indicates a delisting event from the US market effective around January 09, 2026. No additional details on reasons, financial impacts, transaction values, or other metrics are disclosed.
09-01-2026
High Roller Technologies, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001753926-26-000084, Size: 390 KB), reporting multiple items including entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), departure/election of directors or officers and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item mandatory filing classified as a Material Event, but specific transaction details, values, or parties are NOT_DISCLOSED. Sector is not specified.
09-01-2026
CEMTREX INC filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001101, Size: 691 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, events, transaction value, or financial impacts are disclosed in the provided summary. Sector is not specified.
09-01-2026
Company filed Form 8-K on January 9, 2026 (AccNo: 0001628280-26-001630, Size: 629 KB) under Items 1.01 and 9.01, disclosing entry into a Material Definitive Agreement with attached Financial Statements and Exhibits. Event classified as Material Event from US SEC source. No details on agreement terms, parties, transaction value, or financial impacts provided in the filing summary.
09-01-2026
LM Funding America, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008955, Size: 159 KB), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific details on the delisting reason, dollar values, financial impacts, share counts, or sector are disclosed. This appears to be a single-item mandatory disclosure event.
09-01-2026
Fat Brands, Inc. filed an 8-K on 2026-01-09 (AccNo: 0001493152-26-001117) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Event dated January 09, 2026. No sector specified and no additional details such as transaction values or financial impacts disclosed.
09-01-2026
Trio Petroleum Corp filed a Form 8-K on January 09, 2026 (AccNo: 0001493152-26-001116, Size: 676 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. Sector is not specified. No specific details on the agreement, transaction value, financial impacts, or other quantitative data are disclosed.
09-01-2026
Willis Towers Watson PLC filed an 8-K on January 9, 2026 (AccNo: 0001193125-26-009009, Size: 950 KB) reporting under Item 1.01 Entry into a Material Definitive Agreement and Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, with Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, transaction value, or financial impacts are disclosed in the provided summary. This is a multi-item mandatory filing indicating material events.
09-01-2026
TruGolf Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001110, Size: 200 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific details on the core event, reasons for delisting, financial impacts, transaction values, or other quantitative data are disclosed. Sector is not specified.
09-01-2026
Monte Rosa Therapeutics, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-009005, size 677 KB), reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No details on the core event, transaction value, parties involved, financial impacts, or strategic importance are disclosed in the provided information. This is a multi-item filing with no quantitative data available.
09-01-2026
BRAINSTORM CELL THERAPEUTICS INC. filed a Form 8-K on January 9, 2026 (AccNo: 0001104659-26-002494, Size: 1 MB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory disclosure with no specific details on the agreement, transaction values, share counts, or other quantitative data provided in the summary. Sector is not specified.
09-01-2026
Unnamed company filed Form 8-K on January 9, 2026 (AccNo: 0001193125-26-009027, size 271 KB), reporting entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, other events under Item 8.01, and financial statements/exhibits under Item 9.01. This is classified as a Material Event from US SEC source. No specific details on the transaction, parties, amounts, or impacts are disclosed in the provided filing summary.
09-01-2026
Momentus Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001140361-26-000853, Size: 1 MB), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). This is a multi-item filing with no specific details on the agreement, transaction size, or equity sales provided in the summary. Sector not specified.
09-01-2026
Western Union Co filed Form 8-K on 2026-01-09 (AccNo: 0001193125-26-009094) reporting Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), along with Item 9.01 (Financial Statements and Exhibits). This is a multi-item mandatory filing with no specific transaction details, dollar values, counterparties, or financial metrics disclosed. Filing size is 1 MB; sector not specified.
09-01-2026
FLYEXCLUSIVE INC. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-009100, Size: 986 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, or exhibits provided in the available information. Sector is not specified.
09-01-2026
NKGen Biotech, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001213900-26-003030, Size: 370 KB), reporting under Item 1.01 Entry into a Material Definitive Agreement, Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, and Item 9.01 Financial Statements and Exhibits. No specific details on the agreement, financial obligation, transaction value, parties involved, or impacts are disclosed in the provided summary. Sector is not specified.
09-01-2026
Brag House Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001213900-26-003029, Size: 189 KB), reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No specific reasons for delisting, exchange involved, financial impacts, or transaction details are disclosed. Sector is not specified.
Get daily alerts with 4 investment signals, 4 risk alerts, 4 opportunities and full AI analysis of all 33 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC